 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Life Tech Sees Clinical Promise for NGS Panels, Exomes; Says Multiple Platforms to Drive Dx Strategy
August 01, 2012
Life Tech Sees Clinical Promise for NGS Panels, Exomes; Says Multiple Platforms to Drive Dx Strategy
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech Bets on NGS for Pediatric Dx via Boston Children's Spinout as it Continues Drive into Clinical Market
January 9, 2013 / Clinical Sequencing News - Life Tech, Boston Children's Hospital Launch New Company to Focus on Pediatric Disease Diagnostics
January 8, 2013 / GenomeWeb Daily News - Life Tech to Partner with Dx Companies on Clinical Use of Ion Torrent
February 8, 2012 / Clinical Sequencing News - Life Technologies CEO Provides Further Details on Ion Proton
January 10, 2012 / GenomeWeb Daily News - Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
January 22, 2013 / In Sequence